Sightful Invest
  • Business
  • Investing
  • Politics
  • Stock
Top Posts
Nasdaq moves into correction territory as Iran war...
FAA investigating close call involving United Airlines plane...
Judge blocks Trump administration from limiting Anthropic’s contracts...
Senate agrees to fund DHS, except ICE and...
Don Jr.’s shadow hangs over Trump mine fight...
AAP faces pressure over trans youth care, guiding...
Spanberger takes fire from all sides as Youngkin,...
House conservatives rage against Senate DHS shutdown deal
Indicted Democrat Rep Sheila Cherfilus-McCormick one step closer...
Biden judge freezes Trump administration’s move against AI...
  • Business
  • Investing
  • Politics
  • Stock

Sightful Invest

Politics

Pro-life group urges Senate to press RFK Jr. on abortion pill safety, demand safeguards return

by admin September 4, 2025
September 4, 2025
Pro-life group urges Senate to press RFK Jr. on abortion pill safety, demand safeguards return

The Restoration of America Foundation (ROAF) is calling on the Senate Finance Committee to hold Health and Human Services Secretary Robert F. Kennedy Jr. accountable at Thursday’s 10 a.m. hearing, demanding answers about the removal of safety protocols for the abortion pill mifepristone.

In a letter provided exclusively to Fox News Digital, ROAF argues the rollback leaves women more vulnerable and shifts costs to taxpayers.

ROAF argues that the Biden-era rollback of Risk Evaluation and Mitigation Strategy (REMS) requirements, safeguards in place for more than two decades, endangers women by allowing abortion pills to be prescribed via telehealth and delivered through the mail.

‘The removal of key Risk Evaluation and Mitigation Strategy (REMS) requirements for mifepristone has eliminated essential safeguards that protected women’s health for over two decades,’ said Doug Truax, founder and CEO of the Restoration of America Foundation. ‘We urge the Senate to demand clear answers about why these safety protocols were removed and when they will be reinstated.’

The Food and Drug Administration originally required mifepristone to be dispensed in person to ensure women were screened for potential complications such as ectopic pregnancy. That changed under the Biden administration, when telehealth prescribing and mail-order delivery were permitted for the first time.

Truax warned that ‘allowing these powerful drugs to be ordered online and sent through the mail without proper medical screening puts women at serious risk.’ He added, ‘Women deserve to know about potential complications and have immediate access to emergency care if needed.’

This post appeared first on FOX NEWS

previous post
US bolsters military presence in Caribbean near Venezuela amid Trump’s efforts to halt drug trafficking
next post
Trump’s political advisors huddle with House GOP over rebranding of the big beautiful bill

You may also like

With Trump’s backing Israel pushes deeper into Gaza...

April 13, 2025

Trump FBI director nominee Kash Patel picks up...

February 19, 2025

Biden returning to White House for first time...

July 23, 2024

Dems’ Gaetz outrage follows long history of questionable...

November 19, 2024

Trump and Biden offer Christmas greetings as US...

December 26, 2024

Federal judge accuses President Biden of attempting to...

December 4, 2024

Rubio says ‘no choice’ but to bring USAID...

February 4, 2025

Antisemitic shooting of Israeli diplomats adds to alarming...

May 23, 2025

Trump admin recalling around 30 ambassadors as part...

December 22, 2025

Climate justice group that trains federal judges accused...

August 15, 2024

Recent Posts

  • Nasdaq moves into correction territory as Iran war weighs on markets
  • FAA investigating close call involving United Airlines plane and Black Hawk helicopter in California
  • Judge blocks Trump administration from limiting Anthropic’s contracts with federal government
  • Senate agrees to fund DHS, except ICE and CBP, in bid to end extreme airport delays
  • Don Jr.’s shadow hangs over Trump mine fight as China retains critical minerals leverage

    Sign up for our newsletter to receive the latest insights, updates, and exclusive content straight to your inbox! Whether it's industry news, expert advice, or inspiring stories, we bring you valuable information that you won't find anywhere else. Stay connected with us!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Categories

    • Business (998)
    • Investing (4,320)
    • Politics (5,220)
    • Stock (4)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: sightfulinvest.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2026 Sightful Invest. All Rights Reserved.